SCI Pharmtech (Taiwan) Today
| 4119 Stock | TWD 97.60 0.10 0.10% |
Performance16 of 100
| Odds Of DistressLess than 9
|
SCI Pharmtech is selling for under 97.60 as of the 26th of November 2024; that is 0.10 percent increase since the beginning of the trading day. The stock's lowest day price was 97.3. SCI Pharmtech has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for SCI Pharmtech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of July 2023 and ending today, the 26th of November 2024. Click here to learn more.
SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemicals in Taiwan. SCI Pharmtech, Inc. was founded in 1987 and is based in Taoyuan City, Taiwan. SCI PHARMTECH operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.. The company has 95.38 M outstanding shares. More on SCI Pharmtech
Moving against SCI Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SCI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SCI Pharmtech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SCI Pharmtech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
SCI Pharmtech (4119) is traded on Taiwan Stock Exchange in Taiwan and employs 14 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SCI Pharmtech's market, we take the total number of its shares issued and multiply it by SCI Pharmtech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SCI Pharmtech operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 95.38 M outstanding shares.
SCI Pharmtech has accumulated about 1.01 B in cash with 280.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.73.
Check SCI Pharmtech Probability Of Bankruptcy
Ownership AllocationSCI Pharmtech shows a total of 95.38 Million outstanding shares. SCI Pharmtech maintains substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check SCI Ownership Details
SCI Pharmtech Risk Profiles
Although SCI Pharmtech's alpha and beta are two of the key measurements used to evaluate SCI Pharmtech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.4895 | |||
| Semi Deviation | 0.2664 | |||
| Standard Deviation | 0.7114 | |||
| Variance | 0.5061 |
SCI Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SCI Pharmtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
SCI Pharmtech Corporate Management
Elected by the shareholders, the SCI Pharmtech's board of directors comprises two types of representatives: SCI Pharmtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SCI. The board's role is to monitor SCI Pharmtech's management team and ensure that shareholders' interests are well served. SCI Pharmtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SCI Pharmtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JunBang Ye | VP | Profile | |
| WenChih Chou | GM Pres | Profile | |
| Deiter Yang | CG Sec | Profile | |
| Michele Seah | VP | Profile | |
| Ricky Liu | Sustainable Mang | Profile |
Additional Tools for SCI Stock Analysis
When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.